Our vision is to become a leading global biopharmaceutical company based in China delivering innovative, transformative medicines to patients in China and around the world.
There is a significant need for innovative medicines in China, however access to many of the innovative therapies available in other parts of the world is lacking, and China's drug development infrastructure has been underutilized. We are dedicated to addressing these issues to bring innovative medicines to patients.
Our near term focus is on developing and commercializing our products in China. We plan to leverage our team's extensive global drug development expertise and insight, combined with our demonstrated understanding of the pharmaceutical industry and the favorable clinical and regulatory environment in China, to rapidly advance our late-stage in-licensed products to market.
Our mission longer term is to utilize our China-based competencies to impact human health worldwide. We have licensed global rights to several products from international biopharma companies and intend to continue to seek further partnerships, and to grow our discovery efforts, to address global unmet needs.